Schroder Investment Management Group
ENZN

Schroder Investment Management Group’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Schroder Investment Management Group’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-886,500
Closed -$957K – 1560
2014
Q3 		$957K Buy
886,500
+529,300
+148% +$653K ﹤0.01% 1018
2014
Q2 		$371K Buy
357,200
+339,000
+1,863% +$323K ﹤0.01% 1091
2014
Q1 		$18.7K Buy
+18,200
New +$18.8K ﹤0.01% 1348

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Schroder Investment Management Group's ENZN Position: Q4 2014 in Review

Schroder Investment Management Group sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 886,500 shares — an estimated $957K sold.

Schroder Investment Management Group first reported a position in ENZN in Q1 2014 and held it in 3 quarters. The position peaked at $957K in Q3 2014. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • Schroder Investment Management Group reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 886,500 ENZON PHARMACEUTICALS INC shares in Q4 2014, an estimated $957K.
  • Schroder Investment Management Group first reported a position in ENZON PHARMACEUTICALS INC in Q1 2014 and held it in 3 quarters.
  • Schroder Investment Management Group's ENZON PHARMACEUTICALS INC position peaked at $957K in Q3 2014.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.